Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin filament complexes are highly conserved GTP-binding proteins that assemble into non-polar filaments, rings, and gauzes, representing the fourth component of the cytoskeleton alongside actin, microtubules, and intermediate filaments (Mostowy & Cossart, 2012, Nature Reviews Molecular Cell Biology). They function as molecular scaffolds for protein recruitment and as diffusion barriers that compartmentalize membranes, playing essential roles in cytokinesis, cell polarity, and vesicle trafficking (Spiliotis, 2018, Journal of Cell Science). In clinical oncology, septins like SEPT9 are significant; its DNA methylation is a validated biomarker for the early detection of colorectal cancer (Song & Li, 2017, Medical Science Monitor). Furthermore, dysregulated septin expression is associated with neurodegenerative diseases, such as Alzheimer's and Parkinson's, where they are found in pathological protein aggregates (Zhai et al., 2020, Frontiers in Cell and Developmental Biology). While specific clinical drugs targeting septins are currently limited, small molecules like forchlorfenuron (FCF) are used in research to disrupt septin dynamics, demonstrating their potential as targets for anti-proliferative and anti-metastatic therapies.
Disruption of septin filament assembly and stabilization of septin-GTP binding to inhibit cytokinesis and scaffold-dependent signaling pathways (Hu et al., 2008, JBC).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin filament complex (SEPT).